Mark Arnold
Chief Executive Officer
Replay available
MarketWise, Inc. (NASDAQ: MKTW) Q2 2022 earnings conference call, held 2022-08-08. Replay captured from the company's public earnings webcast.

Chief Executive Officer
Chief Financial Officer
Analyst, JMP Securities
Analyst, Needham and Company
Analyst, Baird
Analyst, Oppenheimer and Company
Thank you for standing by and welcome to MarketWise second quarter 2022 earnings call. At this time, all participants are in a listen-only mode. A brief question and answer session will follow the formal presentation. If anyone should require operator assistance during the conference, please press star zero on your telephone keypad. As a reminder, this conference is being recorded. I would now like to turn the conference over to Jonathan Shanfield, head of investor relations at MarketWise. Thank you. Good morning, and thank you for joining us on today's conference call to discuss MarketWise's second quarter 2022 financial results. On the call today, we have Mark Arnold, our Chief Executive Officer, and Dale Lynch, our Chief Financial Officer. During the course of today's call, we may make forward-looking statements, including but not limited to statements regarding our guidance on future financial performance, market demand, growth prospects, business strategies and plans, and our ability to attract and retain customers. These forward-looking statements are based on management's current views and assumptions and should not be relied upon as of any subsequent date, and we disclaim any obligation to update any forward-looking statements. Actual results may vary materially from today's statements. Information concerning our risks, uncertainties, and other factors that could cause results to differ from these forward-looking statements are contained in the company's SEC filings, earnings press release, and supplemental information posted on the investor's section of the company's website. Our discussion today will include certain non-GAAP financial measures. These non-GAAP financial measures should be considered in addition to, but not as a substitute for, or an isolatio...